RT Journal Article
SR Electronic
T1 Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.05.20206730
DO 10.1101/2020.10.05.20206730
A1 Githinji, George
A1 de Laurent, Zaydah R.
A1 Mohammed, Khadija Said
A1 Omuoyo, Donwilliams O.
A1 Macharia, Peter M.
A1 Morobe, John M.
A1 Otieno, Edward
A1 Kinyanjui, Samson M.
A1 Agweyu, Ambrose
A1 Maitha, Eric
A1 Kitole, Ben
A1 Suleiman, Thani
A1 Mwakinangu, Mohamed
A1 Nyambu, John
A1 Otieno, John
A1 Salim, Barke
A1 Kasera, Kadondi
A1 Kiiru, John
A1 Aman, Rashid
A1 Barasa, Edwine
A1 Warimwe, George
A1 Bejon, Philip
A1 Tsofa, Benjamin
A1 Ochola-Oyier, Lynette Isabella
A1 Nokes, D. James
A1 Agoti, Charles N.
YR 2020
UL http://medrxiv.org/content/early/2020/10/07/2020.10.05.20206730.abstract
AB We generated 274 SARS-CoV-2 genomes from samples collected during the early phase of the Kenyan pandemic. Phylogenetic analysis identified 8 global lineages and at least 76 independent SARS-CoV-2 introductions into Kenyan coast. The dominant B.1 lineage (European origin) accounted for 82.1% of the cases. Lineages A, B and B.4 were detected from screened individuals at the Kenya-Tanzania border or returning travellers but did not lead to established transmission. Though multiple lineages were introduced in coastal Kenya within three months following the initial confirmed case, none showed extensive local expansion other than cases characterised by lineage B.1, which accounted for 45 of the 76 introductions. We conclude that the international points of entry were important conduits of SARS-CoV-2 importations. We speculate that early public health responses prevented many introductions leading to established transmission, but nevertheless a few undetected introductions were sufficient to give rise to an established epidemic.Competing Interest StatementD.J.N. is a member of the National COVID-19 Modelling Technical Committee, for the Ministry of Health, Government of Kenya. K.K., R.A., J.K. are from the Ministry of Health, Government of Kenya. E.M., B.K., T.S., M.M., J.N., J.O., B.S. are from the respective county departments of health. All other authors declare no competing interests.Funding StatementThis work was supported by the National Institute for Health Research (NIHR) (project references 17/63/82 and 16/136/33 using UK aid from the UK Government to support global health research, The UK Department for International Development (DfID) and Wellcome Trust (grant# 102975; 220985)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The samples were collected under the Kenya Ministry of Health (MoH) protocols as part of the national response to the COVID-19 pandemic. The whole genome sequencing study protocol was reviewed and approved by the Scientific and Ethics Review Committee (SERU) that sits at the Kenya Medical Research Institute (KEMRI) headquarters in Nairobi (SERU # 4035).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSARS-CoV-2 sequence data used in this analysis are publicly available from GSAID Source code that was used in the analysis of this work is available from GitHub (https://github.com/george-githinji/SARS-CoV-2_KE) and data used to create the figures can also be found in the supplemental files. https://github.com/george-githinji/SARS-CoV-2_KE